{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T18:57:28Z","timestamp":1722970648778},"reference-count":51,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T00:00:00Z","timestamp":1190851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>The present study was designed to investigate the potential antifibrotic and anti\u2010oxidant effects of lisinopril, fosinopril and losartan in an experimental rat model of liver injury using carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>).<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>First, the potential hepatoprotective dose of each drug was screened against CCl<jats:sub>4<\/jats:sub>\u2010induced acute hepatotoxicity. Then, we chose the minimum hepatoprotective dose of each drug to further investigate the mechanisms involved in the hepatoprotection using a chronic model of hepatotoxicity induced by CCl<jats:sub>4<\/jats:sub>.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Liver function was assessed in addition to histopathological examination. Furthermore, oxidative stress markers (reduced glutathione (GSH) and lipid peroxides levels) and markers of fibrosis (hydroxyproline content and liver fibrosis area) were assessed.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>It was found that treatment of animals with different drugs concomitantly with CCl<jats:sub>4<\/jats:sub> significantly counteracted the changes in liver function induced by CCl<jats:sub>4<\/jats:sub> (except fosinopril). In addition, the drugs ameliorated the histopathological changes induced by CCl<jats:sub>4<\/jats:sub>. All drugs significantly counteracted lipid peroxidation and GSH depletion (except fosinopril) compared with the CCl<jats:sub>4<\/jats:sub>\u2010intoxicated group. Moreover, the drugs studied significantly reduced liver hydroxyproline levels and the area of fibrosis compared with the CCl<jats:sub>4<\/jats:sub>\u2010intoxicated group.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In conclusion, the present study provides evidence for the hepatoprotective effect of lisinopril, fosinopril and losartan. Both lisinopril and losartan was found to have better hepatoprotective potential than fosinopril against CCl<jats:sub>4<\/jats:sub>\u2010induced hepatotoxicity. These hepatoprotective effects can be explained on the basis of anti\u2010oxidant and antifibrotic mechanisms, mainly enhancement of GSH and reduction of lipid peroxidation and fibrosis.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p>","DOI":"10.1111\/j.1440-1681.2007.04797.x","type":"journal-article","created":{"date-parts":[[2007,9,29]],"date-time":"2007-09-29T04:34:08Z","timestamp":1191040448000},"page":"159-167","source":"Crossref","is-referenced-by-count":16,"title":["INHIBITION OF THE RENIN\u2013ANGIOTENSIN SYSTEM ATTENUATES THE DEVELOPMENT OF LIVER FIBROSIS AND OXIDATIVE STRESS IN RATS"],"prefix":"10.1111","volume":"35","author":[{"given":"Ebtehal","family":"El\u2010Demerdash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar M Abdel","family":"Salam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seham A","family":"El\u2010Batran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba MI","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermeen M","family":"Shaffie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,9,27]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0098-2997(00)00004-2"},{"key":"e_1_2_5_3_2","first-page":"343","article-title":"Role of free radicals in liver diseases and hepatic fibrosis","volume":"41","author":"Britton RS","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2650659"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.4.2247"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)61001-7"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-003-0009-7"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24282"},{"key":"e_1_2_5_9_2","first-page":"461","article-title":"Using ACE inhibitors appropriately","volume":"66","author":"Bicket DP","year":"2002","journal-title":"Am. Fam. Physician"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01126-3"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2005.03.009"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/10715769309111600"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00211-3"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(99)00115-1"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199503000-00014"},{"key":"e_1_2_5_16_2","first-page":"L1013","article-title":"Captopril inhibits apoptosis in human lung epithelial cells: A potential antifibrotic mechanism","volume":"275","author":"Uhal BD","year":"1998","journal-title":"Am. J. Physiol"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000013417"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36561"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000043369.88701.5b"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(89)90050-8"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90919-3"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4832-2845-7.50012-8"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-8741(97)01524-9"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/28.1.56"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-265X(70)90045-7"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000459586"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(79)90738-3"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(59)90090-6"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(61)90291-0"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v6.i6.824"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1998.8547"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(80)90540-9"},{"key":"e_1_2_5_33_2","first-page":"24","volume-title":"Diagnostic Enzymology","author":"Zimmerman HJ","year":"1970"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1999.276.3.G622"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.1685"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(01)00102-4"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199732060-00003"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.40.1.43"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2150441"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-002-0824-5"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-958032"},{"key":"e_1_2_5_42_2","first-page":"43","article-title":"Xenobiotics, drug metabolism and liver injury","volume":"28","author":"Farber JL","year":"1987","journal-title":"Monogr. Pathol"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2220001"},{"key":"e_1_2_5_44_2","first-page":"658","article-title":"Reactive oxygen species. Oxidative damage and pathogenesis","volume":"77","author":"Bandyopadhyay U","year":"1999","journal-title":"Curr. Sci"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i42.6684"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i24.3924"},{"key":"e_1_2_5_47_2","doi-asserted-by":"crossref","first-page":"F122","DOI":"10.1152\/ajprenal.2000.278.1.F122","article-title":"Age\u2010related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine","volume":"278","author":"Cruz CI","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(00)00270-9"},{"key":"e_1_2_5_49_2","first-page":"43","article-title":"Protective effect of lisinopril against ischemia\u2010reperfusion injury in isolated guinea pig hearts","volume":"42","author":"Dogan R","year":"2001","journal-title":"J. Cardiovasc. Surg"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2460503"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i8.1141"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01518-2"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2007.04797.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2007.04797.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T09:51:17Z","timestamp":1696931477000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2007.04797.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,27]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1440-1681.2007.04797.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2007.04797.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,27]]}}}